Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 590 across all filing types
Latest filing 2011-08-24 Regulatory Filings
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
Health Quest Radiation Oncology väljer RayStation®
Regulatory Filings Classification · 97% confidence The document is a press release dated August 24, 2011, announcing a new order for the RayStation® planning system from Health Quest Systems. It details the customer, the scope of the order (including advanced features like multi-objective optimization), and includes quotes from management and customers. This type of announcement, focusing on a specific business win or contract, is best classified as a general business update or announcement that doesn't fit the strict definitions of earnings (ER), capital changes (CAP), or director dealings (DIRS). Since it is a specific business development announcement, and not a formal regulatory filing like a 10-K or a general regulatory notice (RNS), it most closely aligns with a general business/corporate announcement. Given the provided categories, and since it is not a formal financial report, management discussion, or capital event, the most appropriate general category for a specific business contract announcement that doesn't fit elsewhere is 'Regulatory Filings' (RNS) as a catch-all for non-standard corporate news, although 'RPA' (Report Publication Announcement) is sometimes used for press releases, this document is the news itself, not an announcement *of* a report. However, looking closely at the definitions, none perfectly capture a 'New Contract Win Press Release'. Since it is a formal press release announcing a significant business event (a large order), and it is not a financial report, management discussion, or capital event, it falls best under the general regulatory/announcement category, RNS, as a fallback for specific corporate news not covered elsewhere.
2011-08-24 Swedish
RayStation® order from New York Cancer Center
Regulatory Filings Classification · 97% confidence The document is a press release dated August 18, 2011, announcing a specific business event: the receipt of an order for the RayStation® treatment planning system from a customer (Advanced ROS). It details the customer, the product ordered, and includes quotes from management. This type of announcement, which is a specific operational or commercial update that doesn't fit neatly into standard financial reporting categories (like 10-K, ER, or IR), is best classified as a general Regulatory Filing or announcement. Since there is no specific category for 'Business Contract Announcement' or 'Order Win', and it is not a transcript, management discussion, or financial report, the most appropriate fallback is 'Regulatory Filings' (RNS), as it is a formal public announcement of a material event.
2011-08-18 English
Ny order på RayStation® från cancercenter i New York
Regulatory Filings Classification · 98% confidence The document is a press release dated August 18, 2011, announcing a new order for the RayStation® system from a cancer center in New York. It details the order, quotes management, and provides background information on the product and the company (RaySearch Laboratories AB). This type of announcement, which is a specific business update (a new contract/order) but does not fit neatly into the defined financial reporting categories (like 10-K, ER, IR, or CAP), is best classified as a general regulatory announcement or miscellaneous filing. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for specific, non-standard corporate news releases that are not explicitly defined elsewhere. It is not an Earnings Release (ER), Interim Report (IR), or Capital/Financing Update (CAP), as it is a sales announcement, not a financial performance summary or fundraising activity.
2011-08-18 Swedish
Cancercenter i New Jersey väljer RayStation®
Regulatory Filings Classification · 97% confidence The document is a press release dated August 3, 2011, announcing that RaySearch Laboratories AB has received an order for its RayStation® dose planning system from The Valley Hospital Cancer Center in New Jersey. The content focuses on a specific business transaction (a new customer order/sale) and includes quotes from management and the customer regarding the product's features and the strategic importance of the sale. This type of announcement, detailing a significant business event or contract win, does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a general business update or announcement. Since it is not a standard regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ), and it's not a presentation (IP) or a transcript (CT), the most appropriate general category for a significant, non-financial-result-focused announcement that doesn't fit elsewhere is the general Regulatory Filings fallback category (RNS), as press releases often serve this function in regulatory contexts, or potentially a Capital/Financing Update (CAP) if the order was deemed highly material to future revenue, but RNS is safer for a general contract announcement.
2011-08-03 Swedish
New Jersey Cancer Center Selects RayStation®
Regulatory Filings Classification · 96% confidence The document is a press release dated August 3, 2011, announcing that The Valley Hospital Cancer Center in New Jersey has ordered RaySearch Laboratories' RayStation® treatment planning system. This is a commercial announcement detailing a specific business contract/order win, not a mandatory regulatory filing like a 10-K, an earnings report (ER), or a management change (MANG). It does not fit the definitions for AGM-R, AR, CT, CAP, DVA, DLST, DIRS, SR, XLSX, FS, CGR, IRAT, IR, IP, LTR, TAR, MRQ, NAV, DIV, PSI, DEF 14A, RPA, SHA, or POS. Since it is a specific business announcement that doesn't fit the other specialized categories, it is best classified as a general Regulatory Filing (RNS), as it is a public disclosure of a significant business event, often filed with regulatory bodies as a general announcement.
2011-08-03 English
Conversion of shares - Correction
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a press release dated July 29, 2011, titled "Conversion of shares - Correction." It details a correction regarding a previous announcement about the conversion of Class A shares to Class B shares, which affects the total number of votes and the share structure. This type of announcement, dealing with changes in the capital structure (specifically share class conversion affecting voting rights and share count), aligns best with the 'Share Issue/Capital Change' category (SHA). Although it mentions a correction to a previous release, the core subject matter is the change in the capital structure.
2011-07-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.